Company intelligence / Profile preview

RxFDP

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

RxFDP was a specialized strategy consulting firm focused on the healthcare and life sciences industries, founded by Fredric Price in 1986. During its five years of operation, the firm provided strategic advisory services to pharmaceutical and biotechnology companies on business development, marketing, and commercialization. The firm is notable primarily for its founder, who transitioned from RxFDP to become a significant figure in the biotechnology sector, serving as the CFO of Regeneron Pharmaceuticals and the CEO of several public companies including BioMarin Pharmaceutical, Chiasma, and Bioblast Pharma. RxFDP ceased operations in 1991 when Price joined Regeneron as Vice President of Finance and Administration.

Industry: Consulting

Beyond the preview

Go deeper on RxFDP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxFDP.

Explore the full profile